Age (years) | 64.0 ± 11.1 [37–79] |
Gender (male/female) | 17/15 |
Body mass index (kg/m2) | 26.0 ± 5.3 |
Duration of diabetes (years) | 11.3 ± 12.8 [1–45] |
Diabetes therapy | Â |
Diet only | 15 (47.0) |
Sulfonylurea | 9 (28.0) |
Pioglitazone | 5 (16.0) |
Metformin | 6 (19.0) |
α-glucosidase inhibitor | 3 (9.0) |
Dipeptidyl peptidase-4 inhibitor | 7 (22.0) |
Insulin | 5 (15.6) |
Other treatments | Â |
Lipid-lowering drugs | 13 (41.0) |
Antihypertensive drugs | 14 (44.0) |
Current smokers | 8 (25.0) |
Prevalence cardiovascular disease | 7 (22.0) |
Systolic blood pressure (mmHg) | 135.1 ± 20.0 |
Diastolic blood pressure (mmHg) | 78.3 ± 12.5 |
LDL-cholesterol (mg/dl) | 121.3 ± 23.8 |
HDL-cholesterol (mg/dl) | 50.5 ± 16.9 |
Triglyceride (mg/dl) | 119.8 ± 60.1 |
HbA1c (%) | 7.3 ± 0.5 [6.2-7.9] |
1,5-anhydro-D-glucitol (μg/ml) | 7.4 ± 3.5 [2.6-15.3] |
Fasting plasma glucose (mg/dl) | 128.1 ± 25.3 [75–185] |
Immunoreactive insulin (μU/ml)a | 8.4 ± 8.6 |
HOMA-IRa | 2.6 ± 2.4 |
L_RHI | 0.6 ± 0.2 |